KEGG   GLYCAN: G00056
Entry
G00056                      Glycan                                 
Name
III3,IV2Fuc-nLc4Cer;
IV2-a-Fuc,III3-a-Fuc-nLc4Cer;
Ley glycolipid
Composition
(Gal)2 (Glc)1 (GlcNAc)1 (LFuc)2 (Cer)1
Mass
981.9 (Cer)
Structure
Remark
Same as: C22476
Reaction
R06095
Pathway
map00601  Glycosphingolipid biosynthesis - lacto and neolacto series
map01100  Metabolic pathways
Enzyme
2.4.1.65        2.4.1.152       2.4.1.-
Brite
Lipids [BR:br08002]
 SP  Sphingolipids
  SP05 Neutral glycosphingolipids
   SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)
    G00056  Fuc-alpha1->2Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer
Reference
1  [PMID:2960671]
  Authors
Holmes EH, Hakomori S, Ostrander GK.
  Title
Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1----3N-acetylglucosaminyltransferase.
  Journal
J Biol Chem 262:15649-58 (1987)
Other DBs
LinkDB
KCF data

NODE        7
            1   Cer        17     0
            2   Glc        11     0
            3   Gal         5     0
            4   GlcNAc     -2     0
            5   Gal       -10     5
            6   LFuc      -10    -5
            7   LFuc      -17     5
EDGE        6
            1     2:b1    1:1  
            2     3:b1    2:4  
            3     4:b1    3:3  
            4     5:b1    4:4  
            5     6:a1    4:3  
            6     7:a1    5:2

DBGET integrated database retrieval system